Curious about the stocks that are showing activity after the closing bell on Monday?
By Mill Chart
Last update: Mar 18, 2024
What's going on in today's after hours session
After hours gainers
| Ticker | Change | Comment |
|---|---|---|
| OTRK | 88.42% | Positive market activity for ONTRAK INC (NASDAQ:OTRK) after regular trading hours, with a 88.42% increase to $0.36 in the after-hours session on Monday. In the last 3 months the stock lost 54.76%. |
| UPC | 25.16% | UNIVERSE PHARMACEUTICALS INC (NASDAQ:UPC) exhibits strong performance after hours, with shares rising 25.16% to $1.94 during Monday's after-hours session. Shareholders saw the stock price going 36.99% lower in the past month. |
| GOEVW | 20.0% | HENNESSY CAPITAL ACQUIS-CW25 (NASDAQ:GOEVW) exhibits strong performance after hours, with shares rising 20.0% to $0.12 during Monday's after-hours session. The positive market sentiment seen in today's regular session, where NASDAQ:GOEVW closed with a 53.85% gain, carries over into the after-hours session. |
| AUGX | 18.32% | Impressive after-hours gains for AUGMEDIX INC (NASDAQ:AUGX) as its stock price advanced 18.32% to $3.94 during Monday's after-hours session. yesterday the company released their earnings. In the last month the share price dropped with 28.85%. |
| WORX | 15.43% | SCWORX CORP (NASDAQ:WORX) rose 15.43% to $2.17 during Monday's after hours session. In the last month the stock gained 27.03%. |
| NCMI | 12.56% | NATIONAL CINEMEDIA INC's (NASDAQ:NCMI) stock price increased by 12.56% to $4.75. Earlier today the company had a press release: National CineMedia, Inc. Reports Results for Fiscal Fourth Quarter and Full Year 2023. |
| CATX | 11.46% | After the regular session, PERSPECTIVE THERAPEUTICS INC (NYSEARCA:CATX) continues to impress in the after-hours session, with a 11.46% increase to $1.07. After today's drop of -10.28%, it looks like it is bouncing back during today's after hours session. |
| ATRA | 10.76% | ATARA BIOTHERAPEUTICS INC's (NASDAQ:ATRA) stock price increased by 10.76% to $0.66. NASDAQ:ATRA released their earnings today. Shareholders saw the stock price going 22.71% lower in the past month. |
| UPXI | 9.09% | UPEXI INC's (NASDAQ:UPXI) stock price increased by 9.09% to $0.6. In the last month the share price dropped with 32.66%. |
| MIMO | 9.09% | AIRSPAN NETWORKS HOLDINGS IN's (NYSEARCA:MIMO) stock price increased by 9.09% to $0.12. In the last month the share price dropped with 22.15%. |
For the full after hours gainers list go to our after hours gainers page.
Today's after hours losers
| Ticker | Change | Comment |
|---|---|---|
| GWAV | -50.4% | Price volatility persists as NASDAQ:GWAV closed the regular session with a 23.1% loss, and the downward trend continues in the after-hours session. Following today's 23.1% gain, NASDAQ:GWAV experiences a 50.4% decline in today's after-hours session. |
| PRSO | -22.99% | Price volatility persists as NASDAQ:PRSO closed the regular session with a %ABSPERF% loss, and the downward trend continues in the after-hours session. Today NASDAQ:PRSO released their earnings. In the last 3 months the share price dropped with 84.11%. |
| ACXP | -21.24% | ACURX PHARMACEUTICALS INC's (NASDAQ:ACXP) stock price is showing a decline of 21.24% to a price of $2.04 during the after-hours session. The company's earnings where released Yesterday. In the last 3 months the share price dropped with 32.02%. |
| BTTX | -19.28% | BETTER THERAPEUTICS INC's (NASDAQ:BTTX) shares fell 19.28% to $0.04. Today's after-hours session indicates a reversal in NASDAQ:BTTX's earlier 27.43% gain, with prices exhibiting heightened volatility. |
| AFIB | -13.63% | ACUTUS MEDICAL INC's (NASDAQ:AFIB) stock price is showing a decline of 13.63% to a price of $0.23 during the after-hours session. Price volatility intensifies as NASDAQ:AFIB retraces its 34.43% gain during the after-hours session. |
| DLO | -10.34% | DLOCAL LTD's (NASDAQ:DLO) shares experienced a 10.34% decrease to $16.3 in the after-hours session. yesterday the company released their earnings. A press release (dLocal Appoints Dr. Verónica Raffo as Independent Board Member) was released earlier today. |
| STNE | -8.99% | STONECO LTD-A's (NASDAQ:STNE) stock price saw a decrease of 8.99% to $15.9 during Monday's after-hours session. STONECO LTD-A released earnings Yesterday. The stock is trading 64.19% higher than 6 months ago. |
| NCNA | -8.69% | NUCANA PLC-ADR's (NASDAQ:NCNA) shares experienced a 8.69% decrease to $0.34 in the after-hours session. In the last 3 months the share price increased with 43.92%. |
| CMTL | -8.26% | COMTECH TELECOMMUNICATIONS's (NASDAQ:CMTL) shares declined by 8.26% to $4.22 during Monday's after-hours session. COMTECH TELECOMMUNICATIONS released earnings Yesterday. The stock is trading 35.66% lower than a month ago. |
| EYEN | -6.54% | Following a %ABSPERF% loss in the regular session, NASDAQ:EYEN exhibits further decline during today's after-hours session. EYENOVIA INC released earnings Yesterday. Shareholders saw the stock price going 48.66% lower is the past year. |
For the full after hours loser list go to our after hours losers page.
ACURX PHARMACEUTICALS INC
NASDAQ:ACXP (4/23/2024, 11:29:04 AM)
1.99
+0.01 (+0.51%)
ACXP News
2 hours ago - Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...
a month ago - InvestorPlaceACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q4 2023ACXP stock results show that Acurx Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023.
a month ago - BusinessInsiderACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Acurx Pharmaceuticals (NASDAQ:ACXP) just reported results for the fourth quarte...
a month ago - Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new...
2 months ago - Acurx Pharmaceuticals, Inc.Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update/PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of...
2 months ago - AB NewswireNew to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV2 months ago - Acurx Pharmaceuticals, Inc.Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU DevelopmentAs previously announced, planning is underway with FDA to advance ibezapolstat into international Phase 3 clinical trials for treatment of C. difficile...
3 months ago - Acurx Pharmaceuticals, Inc.Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI PatientsIn the Phase 2b trial, 100% (5 of 5) of ibezapolstat-treated patients who agreed to observation for up to three months following Clinical Cure of CDI...
3 months ago - AB NewswireAcurx Pharmaceuticals’ Phase 2b Results For Ibezapolstat Bests Standard Of Care Vancomycin To Treat C. Difficile ($ACXP)
3 months ago - Seeking AlphaAcurx stock plunges 26% amid Phase 2 data release for C. diff drug (NASDAQ:ACXP)Acurx (ACXP) stock plunged 26% in midday trading amid the release of data from a Phase 2b clinical trial for its C. diff treatment ibezapolstat. Read more here.
3 months ago - Seeking AlphaELAB, KIND and RLX among pre-market losers (NASDAQ:ACXP)Losers: DatChat (DATS) -32% plans to sell shares through public offering.Acurx Pharmaceuticals (NASDAQ:ACXP) -24% announces positive comparative...
